A first-of-its-kind programme to improve the early diagnosis of rheumatoid arthritis has been launched in Qatar, UAE, Kuwait, and Bahrain.
The ‘Enhance’ programme has established Centers of Excellence in many hospitals, including Hamad Ge
Roche has won European backing for broader use of its arthritis drug RoActemra to treat children with a rare and severe form of the disease, the Swiss drugmaker said.
The medicine, known as Actemra outside of Europe, is already used to tre
The Lebanese Ministry of Public Health has announced the launch of a nation-wide awareness campaign to tackle Rheumatoid Arthritis (RA), a chronic, progressive inflammatory disease of the joints and surrounding tissues.
RA is associated wi
Swiss drugmaker Roche Holding AG and America's Biogen Idec are suspending rheumatoid arthritis and lupus treatment Ocrelizumab after it caused deaths, marking the latest setback for Roche's pipeline.
A safety monitoring board said it
In a recent study published in a leading American journal, Arthritis and Rheumatism, researchers have identified many gaps in care of Rheumatoid Arthritis (RA) patients in the UAE as compared with Western countries.
In the UAE, only
UAE doctors have said delay in the diagnosis and treatment of Arthritis can lead to deformities or worse.
Health professionals are urging the Ministry of Health to take an active role in the promotion of Rheumatoid Arthritis after local re
Enoc has extended its support to the Women’s Initiative for Rheumatoid Arthritis (Wira), the ongoing campaign aimed at raising awareness on rheumatoid arthritis, a crippling bone and joint disorder which is highly prevalent among women in the UAE
Patients in the UAE had a lag time of nearly one year in detection of Rheumatoid Arthritis (RA) and another nine months before they received the correct treatment, according to a medical study.
A leading European journal Annals
The four-week educational campaign to raise awareness of arthritis proved a great success across the GCC, a statement said.
More than 16 live TV and radio interviews were conducted with high profile rheumatologists in the UAE, Qatar, Oman,